bicnu 100mg powder for injection vial with diluent vial
emcure pharmaceuticals pty ltd - carmustine, quantity: 100 mg - injection, powder for - excipient ingredients: - indications as at 16 december 1985: carmustine is indicated as palliative therapy as a single agent or in established combination therapy with other approved chemotherapeutic agents in the following: 1. malignant glioma. 2. multiple myeloma: in combination with prednisone. 3. hodgkin's disease: as secondary therapy in combination with other approved drugs in patients who relapse while being treated with primary therapy, or who fail to respond to primary therapy. 4. non-hodgkins lymphomas: as secondary therapy in combination with other approved drugs for patients who relapse while being treated with primary therapy or who fail to respond to primary therapy.
viropil tablets film-coated
emcure pharmaceuticals ltd. - dolutegravir (dolutegravir sodium), lamivudine, tenofovir disoproxil fumarate - tablets film-coated - 50mg+ 300mg+ 300mg
emexed pemetrexed (as disodium) 500 mg powder for injection vial
emcure pharmaceuticals pty ltd - pemetrexed disodium hemipentahydrate, quantity: 604.1 mg (equivalent: pemetrexed, qty 500 mg) - injection, powder for - excipient ingredients: mannitol; sodium hydroxide; hydrochloric acid; nitrogen - malignant pleural mesothelioma pemetrexed, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,non-small cell lung cancer pemetrexed in combination with cisplatin is indicated for initial treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.,pemetrexed as monotherapy is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology after prior platinum-based chemotherapy.
teri-em teriflunomide 14 mg tablet blister pack
emcure pharmaceuticals pty ltd - teriflunomide, quantity: 14 mg - tablet, film coated - excipient ingredients: hyprolose; maize starch; microcrystalline cellulose; sodium starch glycollate type a; silicon dioxide; lactose monohydrate; magnesium stearate; titanium dioxide; macrogol 8000; hypromellose; purified talc; indigo carmine aluminium lake - teriflunomide is indicated for the treatment of patients with relapsing forms of multiple sclerosis to reduce the frequency of clinical relapses and to delay the progression of physical disability.
asomex-d
emcure pharmaceuticals ltd. - amlodipine (amlodipine besilate), hydrochlorothiazide - tablets - 2,5mg+12,5mg
inbec tablet, film-coated 600/50/300 mg
emcure pharmaceuticals limited, india - abacavir,dolutegravir , lamivudine - tablet, film-coated - 600/50/300 mg
lavem tablet
emcure- pharmaceutical south africa (pty) ltd - tablet - see ingredients - each tablet contains dolutegravir 50,0 mg lamivudine 300,0 mg tenofovir disoproxil fumarate 300,0 mg
asomex-5
emcure pharmaceuticals ltd. - amlodipine (amlodipine besilate) - tablets - 5mg
asomex-2,5
emcure pharmaceuticals ltd. - amlodipine (amlodipine besilate) - tablets - 2,5mg
panpure
emcure pharmaceuticals ltd. - pantoprazole (pantoprazole sodium) - tablets enteric-coated - 20mg